Point-of-Care Test Strip for Simultaneous G6PD and Hemoglobin Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic tools are inadequate for identifying individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, which poses a risk during primaquine treatment for malaria, particularly in rural areas affected by Plasmodium vivax, leading to untreated infections and potential mortality.

Innovation Solution

A test strip and diagnostic kit that simultaneously determine G6PD and hemoglobin levels in a biological sample using a combination of membrane layers and reagents, allowing for colorimetric analysis and quantitative determination, enabling point-of-care monitoring with a fingerstick sample.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current diagnostic tools are used to identify G6PD deficiency, then screening accuracy may be maintained, but the complexity and cost of screening increases significantly, making it impractical for widespread use in rural areas

Engineering Contradiction:
ImproveG6PD deficiency screening accuracyVSAvoidscreening process complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines G6PD enzyme activity testing and hemoglobin level measurement into a single test strip with multiple reaction zones. The test strip simultaneously performs both functions using different reagent layers, eliminating the need for separate tests and reducing overall screening complexity while maintaining diagnostic accuracy for both parameters.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The test strip is designed as a multi-functional diagnostic tool that can detect multiple conditions (G6PD deficiency and hemoglobin levels) from a single blood sample. This universal approach allows one device to replace multiple specialized tests, making screening more accessible in resource-limited settings.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If traditional laboratory-based G6PD testing is performed, then diagnostic accuracy is maintained, but the time required for results increases significantly

Engineering Contradiction:
ImproveG6PD diagnosis accuracyVSAvoidtesting time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The test strip divides the diagnostic process into separate functional zones: a first reaction zone for G6PD enzyme activity detection and a second reaction zone for hemoglobin measurement. Each zone contains specific reagents that react with the blood sample independently, allowing parallel processing of multiple tests and rapid simultaneous results without requiring sequential laboratory procedures.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The test strip is designed as a self-contained diagnostic system that requires minimal external equipment or expertise to operate. The reagents are pre-loaded on the strip, and results are generated automatically through colorimetric changes that can be read visually or with simple equipment, eliminating the need for complex laboratory infrastructure and enabling rapid point-of-care testing.

Inventive Principle:
Principle #25Self-service

3Ease of operation

If G6PD screening is not performed before primaquine treatment, then treatment access is improved, but the risk of severe hemolytic anemia increases in G6PD deficient patients

Engineering Contradiction:
Improvetreatment accessibilityVSAvoidhemolytic anemia risk
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The test strip enables preliminary screening for G6PD deficiency and hemoglobin levels before primaquine treatment is administered. By performing quick point-of-care tests prior to treatment, clinicians can identify at-risk patients and adjust dosing or select alternative therapies, preventing severe hemolytic anemia while maintaining treatment accessibility for those who can safely receive primaquine.

Inventive Principle:
Principle #10Preliminary action

4Productivity

If a point-of-care test strip is developed for G6PD testing, then testing speed and accessibility are improved, but the manufacturing precision requirements increase

Engineering Contradiction:
Improvetesting speedVSAvoidtest strip manufacturing precision
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The test strip incorporates different reagent layers with specific properties optimized for their respective functions. The first reaction zone contains enzymes and substrates tailored for G6PD detection, while the second zone contains reagents for hemoglobin measurement. Each zone is manufactured with precise local characteristics, but the overall design uses standardized production techniques that balance manufacturing precision requirements with rapid testing capabilities.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The kit provides rapid, accurate, and easy-to-perform testing for G6PD and hemoglobin levels, enabling identification of individuals who can tolerate or cannot tolerate primaquine treatment, thereby facilitating appropriate malaria therapy and reducing transmission risks.

Implementation Method 1

quantitatively determined colorimetrically

Methodology Applied
Scientific EffectColorimetric analysis: Absorption Spectroscopy

Implementation Method 2

G6PDH, which is either absent, insufficiently present, or in excess

Methodology Applied
Scientific EffectEnzymatic reaction: Enzyme

Implementation Method 3

using, for example, a reflectance-based reader

Methodology Applied
Scientific EffectReflectance: Reflection

Data Source

PatentUS11041860B2Point-of-care device for the colorimetric determination of hemoglobin and glucose-6-phosphate dehydrogenase in biological samples
Publication Date: 2021.06.22 ANALYTICAL DIAGNOSTIC SOLUTIONS INC
  • US11041860B2 patent drawing
  • US11041860B2 patent drawing
  • US11041860B2 patent drawing

AI summary

Devices, kits, and assays are provided for the testing and monitoring of hemoglobin, anemia, glucose-6-phoshate dehydrogenase, and glucose-6-phosphate dehydrogenase deficiency in an individual.